Japanese Journal of Clinical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 39.0% | 0.652 | Q2 | 70.5% |
| 2024 | 2.2 | Q3 | 34.0% | 0.613 | Q2 | 69.1% |
| 2023 | 1.9 | Q3 | 27.8% | 0.612 | Q2 | 71.6% |
| 2022 | 2.4 | Q4 | 31.1% | 0.743 | Q2 | 78.5% |
| 2021 | 2.9 | Q4 | 42.0% | 0.679 | Q2 | 76.5% |
| 2020 | — | — | 0.768 | Q2 | 78.7% | |
| 2019 | — | — | 0.758 | Q2 | 79.0% | |
| 2018 | — | — | 0.806 | Q2 | 78.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1465-3621
ISSN
0368-2811
region
Western Europe
coverage
1971-2026